These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 8605709)
1. Management of moderate to severe hypertension and proteinuria by nifedipine retard and perindopril after renal transplantation. Grekas D; Dioudis C; Kalevrosoglou I; Papoulidou F; Goutsaridis N; Alivanis P; Tourkantonis A Clin Nephrol; 1995 Nov; 44(5):299-302. PubMed ID: 8605709 [TBL] [Abstract][Full Text] [Related]
2. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors. Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523 [TBL] [Abstract][Full Text] [Related]
3. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria. Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C; Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085 [TBL] [Abstract][Full Text] [Related]
4. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies. Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328 [TBL] [Abstract][Full Text] [Related]
5. A double-blind trial of perindopril and nitrendipine in incipient diabetic nephropathy. Kopf D; Schmitz H; Beyer J; Frank M; Bockisch A; Lehnert H Diabetes Nutr Metab; 2001 Oct; 14(5):245-52. PubMed ID: 11806464 [TBL] [Abstract][Full Text] [Related]
6. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
7. Treatment of hypertension in chronic kidney disease. Toto RD Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency. Giri S; Mahajan SK; Sen R; Sharma A J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207 [TBL] [Abstract][Full Text] [Related]
9. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383 [TBL] [Abstract][Full Text] [Related]
10. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study. Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T; Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719 [TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients. Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722 [TBL] [Abstract][Full Text] [Related]
12. Reverse remodeling and improved function by antihypertensive treatment in hypertensive patients with coronary artery disease. Yui Y; Kodama K; Hirayama A; Nishio R; Iwanaga Y; Nonogi H; Haze K; Sumiyoshi T; Yui N; Hosoda S; Kawai C; J Hypertens; 2010 Jan; 28(1):178-85. PubMed ID: 19927011 [TBL] [Abstract][Full Text] [Related]
13. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril. Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension. Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483 [TBL] [Abstract][Full Text] [Related]
15. Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage. Lufft V; Kliem V; Hamkens A; Bleck JS; Eisenberger U; Petersen R; Ehlerding G; Maschek H; Pichlmayr R; Brunkhorst R Clin Transplant; 1998 Oct; 12(5):409-15. PubMed ID: 9787950 [TBL] [Abstract][Full Text] [Related]
16. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study]. Widimský J; Fedelesová V; Uhlír O Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of a combination of a diuretic and nifedipine retard for the treatment of hypertensive patients refractory to nifedipine retard]. Martínez López JJ; Rúiz López FJ; Gómez Márquez M; Ortega González G; Molina Boix M; Florenciano Sánchez R An Med Interna; 1993 Aug; 10(8):386-9. PubMed ID: 8218783 [TBL] [Abstract][Full Text] [Related]
18. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease. Matsuda H; Hayashi K; Saruta T J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy. Bönner G; Lederle RM; Scholze J; Stumpe KO Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441 [TBL] [Abstract][Full Text] [Related]
20. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil]. Widimský J; Dzúrik R Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]